Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvano Adami

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Calcified Tissue International|October 24, 2008
Intramuscular neridronate in postmenopausal women with low bone mineral densitySilvano Adami, Davide Gatti, Francesco Bertoldo, et al.
Mayo Clinic Proceedings|March 13, 2002
Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trialsHugh Taggart, Michael A Bolognese, Robert Lindsay, et al.
The Journal of Rheumatology|July 2, 2004
Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional studyOmbretta di Munno, Maurizio Mazzantini, Luigi Sinigaglia, et al.
Current Medical Research and Opinion|September 19, 2003
Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled studyDavid Hosking, Silvano Adami, Dieter Felsenberg, et al.
Nature Clinical Practice. Rheumatology|April 10, 2008
Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspectivePiet P Geusens, Christian H Roux, David M Reid, et al.
European Journal of Internal Medicine|July 2, 2016
Declining trends in the incidence of hip fractures in people aged 65years or over in years 2000-2011Sandro Giannini, Stefania Sella, Maurizio Rossini, et al.
Bone|July 26, 2011
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosisMaurizio Rossini, Roberta Zanotti, Patrizia Bonadonna, et al.
Advances in Therapy|August 13, 2014
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritidesMarcello Govoni, Alessandra Bortoluzzi, Andrea Lo Monaco, et al.
Journal of the American Geriatrics Society|February 10, 2012
Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal womenSusan L Greenspan, Allison Wyman, Frederick H Hooven, et al.
The Journal of Rheumatology|February 9, 2008
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA studyJohn A Eisman, Roberto Civitelli, Silvano Adami, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Calcified Tissue International|October 24, 2008
Intramuscular neridronate in postmenopausal women with low bone mineral densitySilvano Adami, Davide Gatti, Francesco Bertoldo, et al.
Mayo Clinic Proceedings|March 13, 2002
Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trialsHugh Taggart, Michael A Bolognese, Robert Lindsay, et al.
The Journal of Rheumatology|July 2, 2004
Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross-sectional studyOmbretta di Munno, Maurizio Mazzantini, Luigi Sinigaglia, et al.
Current Medical Research and Opinion|September 19, 2003
Comparison of change in bone resorption and bone mineral density with once-weekly alendronate and daily risedronate: a randomised, placebo-controlled studyDavid Hosking, Silvano Adami, Dieter Felsenberg, et al.
Nature Clinical Practice. Rheumatology|April 10, 2008
Drug Insight: choosing a drug treatment strategy for women with osteoporosis-an evidence--based clinical perspectivePiet P Geusens, Christian H Roux, David M Reid, et al.
European Journal of Internal Medicine|July 2, 2016
Declining trends in the incidence of hip fractures in people aged 65years or over in years 2000-2011Sandro Giannini, Stefania Sella, Maurizio Rossini, et al.
Bone|July 26, 2011
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosisMaurizio Rossini, Roberta Zanotti, Patrizia Bonadonna, et al.
Advances in Therapy|August 13, 2014
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritidesMarcello Govoni, Alessandra Bortoluzzi, Andrea Lo Monaco, et al.
Journal of the American Geriatrics Society|February 10, 2012
Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal womenSusan L Greenspan, Allison Wyman, Frederick H Hooven, et al.
The Journal of Rheumatology|February 9, 2008
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA studyJohn A Eisman, Roberto Civitelli, Silvano Adami, et al.
Pageof 13